Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 3
2017 2
2018 3
2019 2
2020 5
2021 5
2022 5
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Bone marrow adipocytes induce cancer-associated fibroblasts and immune evasion, enhancing invasion and drug resistance.
Sato S, Hiruma T, Koizumi M, Yoshihara M, Nakamura Y, Tadokoro H, Motomatsu S, Yamanaka T, Washimi K, Okubo Y, Yoshioka E, Kasajima R, Yamashita T, Kishida T, Yokose T, Miyagi Y. Sato S, et al. Among authors: kasajima r. Cancer Sci. 2023 Jun;114(6):2674-2688. doi: 10.1111/cas.15786. Epub 2023 Mar 28. Cancer Sci. 2023. PMID: 36916999 Free PMC article.
Genetic analysis of low-grade adenosquamous carcinoma of the breast progressing to high-grade metaplastic carcinoma.
Kawachi K, Tang X, Kasajima R, Yamanaka T, Shimizu E, Katayama K, Yamaguchi R, Yokoyama K, Yamaguchi K, Furukawa Y, Miyano S, Imoto S, Yoshioka E, Washimi K, Okubo Y, Sato S, Yokose T, Miyagi Y. Kawachi K, et al. Among authors: kasajima r. Breast Cancer Res Treat. 2023 Dec;202(3):563-573. doi: 10.1007/s10549-023-07078-9. Epub 2023 Aug 31. Breast Cancer Res Treat. 2023. PMID: 37650999 Free PMC article.
Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia.
Kazama S, Yokoyama K, Ueki T, Kazumoto H, Satomi H, Sumi M, Ito I, Yusa N, Kasajima R, Shimizu E, Yamaguchi R, Imoto S, Miyano S, Tanaka Y, Denda T, Ota Y, Tojo A, Kobayashi H. Kazama S, et al. Among authors: kasajima r. Front Oncol. 2022 Sep 16;12:974307. doi: 10.3389/fonc.2022.974307. eCollection 2022. Front Oncol. 2022. PMID: 36185232 Free PMC article.
Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS Study.
Ikeda S, Kato T, Kenmotsu H, Ogura T, Sato Y, Hino A, Harada T, Kubota K, Tokito T, Okamoto I, Furuya N, Yokoyama T, Hosokawa S, Iwasawa T, Kasajima R, Miyagi Y, Misumi T, Okamoto H. Ikeda S, et al. Among authors: kasajima r. Oncologist. 2022 Sep 2;27(9):720-e702. doi: 10.1093/oncolo/oyac118. Oncologist. 2022. PMID: 35759340 Free PMC article. Clinical Trial.
Histological markers, sickle-shaped blood vessels, myxoid area, and infiltrating growth pattern help stratify the prognosis of patients with myxofibrosarcoma/undifferentiated sarcoma.
Washimi K, Kasajima R, Shimizu E, Sato S, Okubo Y, Yoshioka E, Narimatsu H, Hiruma T, Katayama K, Yamaguchi R, Yamaguchi K, Furukawa Y, Miyano S, Imoto S, Yokose T, Miyagi Y. Washimi K, et al. Among authors: kasajima r. Sci Rep. 2023 Apr 25;13(1):6744. doi: 10.1038/s41598-023-34026-w. Sci Rep. 2023. PMID: 37185612 Free PMC article.
33 results